Skip to main content

Help us celebrate 50 years of the Semel Institute. Learn more

Research Laboratory

UCLA Psilocybin-Assisted CBT Lab

Leadership

Marc Weintraub, Ph.D.
Director

 

About

The primary objectives of this clinical investigation are to (1) determine the acceptability and feasibility of joining psilocybin-assisted therapy with cognitive-behavioral therapy (PA-CBT) for patients with depression, (2) optimize CBT to most effectively integrate the psilocybin experience with psychotherapy and (3) examine the clinical benefit of psilocybin as an adjunct to cognitive-behavioral therapy (CBT) for major depressive disorder.